Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Opinion in Lipidology|June 8, 2018
Towards more specific treatment for diabetic dyslipidemiaValentina Rodriguez, Jonathan D Newman, Arthur Z SchwartzbardCurrent Atherosclerosis Reports|January 10, 2013
Statins and diabetes: the good, the bad, and the unknownKelly Axsom, Jeffrey S Berger, Arthur Z SchwartzbardTexas Heart Institute Journal|January 13, 2011
Ranolazine: a new approach to treating an old problemBharath M Reddy, Howard S Weintraub, Arthur Z SchwartzbardCardiology in Review|August 12, 2010
Fish oil for the treatment of cardiovascular diseaseDaniel Weitz, Howard Weintraub, Edward Fisher, et al.Journal of the American College of Cardiology|April 25, 2020
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus SeminarTanya Wilcox, Christophe De Block, Arthur Z Schwartzbard, et al.Journal of the American College of Cardiology|August 12, 2017
Primary Prevention of Cardiovascular Disease in Diabetes MellitusJonathan D Newman, Arthur Z Schwartzbard, Howard S Weintraub, et al.Journal of the American College of Cardiology|October 6, 2018
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art ReviewJonathan D Newman, Anish K Vani, Jose O Aleman, et al.Journal of the American College of Cardiology|August 20, 2016
Cardiovascular Effects of the New Weight Loss AgentsMatthew H Vorsanger, Pritha Subramanyam, Howard S Weintraub, et al.Coronary Artery Disease|July 4, 2012
Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery diseaseAlana Choy-Shan, Andrew Zinn, Binita Shah, et al.Coronary Artery Disease|February 28, 2008
Metabolic syndrome does not impact survival in patients treated for coronary artery diseaseBinita Shah, Nidhi Kumar, Parveen Garg, et al.Pageof 2